We conclude that (1) an enhancement in NO release is an important cause of β-arrestin1-induced protective response in the RVLM of hypertension, and (2) this effect is underpinned, at least partly, by ERK1/2-mediated nNOS activation. Here, MAPK3 is linked to hypertensive disorder.